Rx Innovation Benefit Is Strongest Argument For Patents, PTO Director Says
Executive Summary
The message that new drugs would not exist without strong patent protections is gaining acceptance from the international intellectual property community, Patent & Trademark Office Acting Director Jon Dudas said Feb. 23